title: What is the essential element(s) to avoid axillary involvement in breast cancer patients?
authors.forename: Mohammad Esmaeil
authors.initials: ME
authors.lastname: Akbari
authors.forename: Mohammad
authors.initials: M
authors.lastname: Hassani
authors.forename: Atieh
authors.initials: A
authors.lastname: Akbari
authors.forename: Nahid
authors.initials: N
authors.lastname: Nafisi
authors.forename: Someieh Sadat
authors.initials: SS
authors.lastname: Naserinia
authors.forename: Rahele
authors.initials: R
authors.lastname: Jafari
authors.forename: Zahra
authors.initials: Z
authors.lastname: Razaghi
mesh_terms: D000328:Adult; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery*; D018567:Breast Neoplasms, Male / Q000473:pathology / Q000601:surgery; D016022:Case-Control Studies; D016001:Confidence Intervals; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007492:Iran; D053208:Kaplan-Meier Estimate; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D021701:Sentinel Lymph Node Biopsy; D011795:Surveys and Questionnaires